Drug/cyclodextrin solid systems in the design of hydrophilic matrices: A strategy to modulate drug delivery rate

Current Drug Delivery

Volumn 3, Issue 4, 2006, Pages 373-378

  Miro, Agnese ^a   Quaglia, Fabiana ^a   Giannini, Lucia ^a   Cappello, Brunella ^a   La Rotonda, Maria Immacolata ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Dipartimento di Chimica Farmaceutica e Tossicologica   (Italy)

Author keywords

Binary systems; Carvedilol; Hydrophilic matrices; Hydroxypropyl cyclodextrin

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CARVEDILOL; MACROGOL;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; PRIORITY JOURNAL; X RAY DIFFRACTION;

ANTIHYPERTENSIVE AGENTS; BETA-CYCLODEXTRINS; CARBAZOLES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DESIGN; PHARMACEUTICAL PREPARATIONS; PROPANOLAMINES; SOLUBILITY; X-RAY DIFFRACTION;

EID: 33749563591     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720106778558994     Document Type: Article

References (28)

1. Siepmann, J.; Peppas, N. A. Adv. Drug Deliv. Rev., 2001, 48 (2-3), 139-157.
2. De Grande, G.; Benes, L.; Horrière, F.; Karsenty, H.; Lacoste, C.; McQuinn, R.; Scherrer R. In Oral Mucosal Drug Delivery, Rathbone M.J., Ed; Drug and the Pharmaceutical Science, Marcel Dekker, New York, 1996, pp. 288-290.
3. Bettini, R.; Castellani, P. L.; Santi, P.; Massimo, G.; Peppas, N. A.; Colombo, P. J. Control. Rel., 2001, 70 (3), 383-391.
4. Apicella, A.; Cappello, B.; Del Nobile, M.A.; La Rotonda, M.I.; Mensitieri, G.; Nicolais, L. Biomaterials, 1993, 14, 83-90.
5. Cappello, B.; Del Nobile, M.A.; La Rotonda, M.I.; Mensitieri, G.; Miro, A.; Nicolais, L. Farmaco, 1994, 49, 809-818.
6. Kim, C.J. J. Pharm. Sci., 1995, 84, 303-306.
7. Tiwari, D.; Goldman, D.; Sause, R.; Madan, P.L. AAPS Pharm. Sci., 1999, 1, E13.
8. Bibby, D. C.; Davies, N. M.; Tucker, I. G. Int. J. Pharm., 2000, 197, 1-11.
9. Loftsson, T.; Brewster, M. E. J. Pharm. Sci., 1996, 85, 1017-1025.
10. Rajewski, R. A.; Stella, V. J. J. Pharm. Sci., 1996, 8, 1142-1169.
11. Davis, M. E.; Brewster, M. E., Nat. Rev., 2004, 3, 1023-1035.
12. Quaglia, F.; Varricchio, G.; Miro, A.; La Rotonda, M. I.; Larobina, D.; Mensitieri, G. J. Control. Release, 2001, 71, 329-337.
13. De Rosa, G.; Larobina, D.; La Rotonda, M. I.; Musto, P.; Quaglia, F.; Ungaro, F. J. Control. Release, 2005, 102, 71-83.
14. Uekama, K.; Matsubara, K.; Abe, K.; Horiuchi, Y.; Hirayama, F.; Suzuki, N. J. Pharm. Sci., 1990, 79, 244-248.
15. Guo, J. H.; Cooklock, K. M. Drug Dev. Ind. Pharm., 1995, 21, 2013-2019.
16. Rao, V. M.; Haslam, J. L.; Stella, V. J. J. Pharm. Sci., 2001, 90, 807-816.
17. Koester, L.S.; Mayorga, P.; Bassani, V.L. Drug Dev. Ind. Pharm., 2003, 29, 139-144.
18. Jug, M.; Becirevic-Lacan, M. Eur. J. Pharm. Sci., 2004, 21, 251-260.
19. Pose-Vilarnovo, B.; Rodriguez-Tenreiro, C.; Rosa dos Santos, J. F.; Vazquez-Doval, J.; Concheiro, A.; Alvarez-Lorenzo, C.; Torres-Labandeira, J. J. J. Control. Rel., 2004, 94, 351-363.
20. Higuchi, T.; Connors, K. A. Adv. Analytical Chem. Inst., 1965, 4, 117-212.
21. Wen, X.; Tan, F.; Jing, Z.; Liu, Z. J. Pharm. Biomed. Anal., 2004, 34 (3), 517-523.
22. Irie, T.; Uekama, K. J. Pharm. Sci., 1997, 86 (2), 147-162.
23. Loftsson, T.; Masson, M.; Brewster, M. E. J. Pharm. Sci., 2004, 93 (5), 1091-1099.
24. Loftsson, T. ; Magnusdottir, A. ; Masson, M. ; Sigurjonsdottir, J. F. J. Pharm. Sci., 2002, 91 (11), 2307-2316.
25. Liu, L.; Guo, Q. X. J. Incl. Phenom. Macr. Chem., 2002, 42, 1-14.
26. Venkatesh, G. M.; Barnett, M. E.; Owusu-Fordjour, C.; Galop, M. Pharm. Res., 2001, 18, 98-103.
27. Li, J.; Li, X.; Toh, K.C.; Ni, X.; Zhou, Z.; Leong, K.W. Macromolecules, 2001, 34, 8829-8831.
28. Li, J.; Ni, X.; Leong, K.W. J. Biomed. Mater. Res. A, 2003, 65, 196-202.